Trial intelligence / Profile preview

Subcutaneous anakinra after aneurysmal subarachnoid haemorrhage

2011-001855-35Phase 2Completed

Sponsor
Salford Royal NHS Foundation Trust
Start
Jun 2011
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2 trial of anakinra in subarachnoid hemorrhage (SAH) (2 arms), sponsored by Salford Royal NHS Foundation Trust. Primary endpoint: Area under the curve of IL-6 concentration from day 3 to day 8 post-ictus. Started Jun 2011; status: completed.

02

Drugs

anakinra
03

Conditions

subarachnoid hemorrhage (SAH)

Beyond the preview

Go deeper on 2011-001855-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-001855-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call